EXICURE INC (XCUR)

US30205M2008 - Common Stock

0.3303  +0 (+0.67%)

After market: 0.329 0 (-0.39%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

EXICURE INC

NASDAQ:XCUR (7/12/2024, 7:09:39 PM)

After market: 0.329 0 (-0.39%)

0.3303

+0 (+0.67%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-60.44%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap2.86M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

XCUR Daily chart

Company Profile

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 7 full-time employees. The company went IPO on 2018-05-09. The firm is developing nucleic acid therapies targeting ribonucleic acid (RNA) to address both genetic and non-genetic neurological disorders. Its lead program is a non-opioid pain analgesic directed against the genetically validated target SCN9A. The company is engaged in discovery efforts across a range of indications and therapeutic targets, such as pain using non-opioid analgesics, as well as rare neurological genetic disorders, including Huntington's disease, Angelman Syndrome, Batten disease, spinocerebellar ataxia, and sporadic amyotrophic lateral sclerosis (ALS). The firm focuses on pursuing out-licensing opportunities for its clinical asset, cavrotolimod, as well as for its preclinical candidates, including the SCN9A program for neuropathic pain.

Company Info

EXICURE INC

2430 N. Halsted St.

Chicago ILLINOIS 60614

P: 18476731700

CEO: David A. Giljohann

Employees: 7

Website: https://www.exicuretx.com/

XCUR News

News Image25 days ago - InvestorPlaceXCUR Stock Earnings: Exicure Reported Results for Q1 2024

Exicure just reported results for the first quarter of 2024.

News Image25 days ago - BusinessInsiderXCUR Stock Earnings: Exicure Reported Results for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exicure (NASDAQ:XCUR) just reported results for the first quarter of 2024.Exicu...

News Image25 days ago - Exicure, Inc.Exicure, Inc. Reports First Quarter 2024 Financial Results
News Imagea month ago - InvestorPlaceXCUR Stock Earnings: Exicure Reported Results for Q4 2023

Exicure just reported results for the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderXCUR Stock Earnings: Exicure Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exicure (NASDAQ:XCUR) just reported results for the fourth quarter of 2023.Exic...

News Imagea month ago - Exicure, Inc.Exicure, Inc. Reports Full Year 2023 Financial Results

XCUR Twits

Here you can normally see the latest stock twits on XCUR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example